MedTrace Logo

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

NCT03870633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 521

Last updated 2025-01-17

No results posted yet for this study

Summary

This trial studies financial difficulty in participants with chronic lymphocytic leukemia and multiple myeloma. Assessment of financial difficulty may help to better understand the financial impact of cancer and come up with ways to help participants avoid financial problems during treatment.

Conditions

Interventions

OTHER

Medical Chart Review

Undergo medical chart abstraction

OTHER

Interview

Complete telephone interview

OTHER

Questionnaire

Ancillary studies

OTHER

Quality-of-Life Assessment

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • The Leukemia and Lymphoma Society

    collaborator OTHER

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Rena M. Conti, PhD · Boston University Questrom School of Business

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-14
Primary Completion
2021-02-01
Completion
2023-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870633 on ClinicalTrials.gov